Erbituxcetuximabinjection,for intravenous use initial u. Xgeva is not indicated for the prevention of skeletalrelated events in patients with multiple myeloma see clinical trials 14. Indications the indications below including fdaapproved indications and compendial uses are considered a covered benefit provided that all the approval criteria are met and the member has no exclusions to the prescribed therapy. This solution is readytouse and may be administered directly to the patient without further preparation. If the next scheduled boniva day is only 1 to 7 days away, wait until the subsequent months scheduled boniva day to take their tablet. Read all of this leaflet carefully before you start using this medicine. Do not pull the back stopper flange off of the syringe.
Posology supplementation of at least 500mgcalcium and 400iu vitamin d daily is required in all patients, unless hypercalcaemia is presentsee section 4. Xgeva is indicated for treatment of adults and skeletally mature adolescents with giant cell tumor of bone that is unresectable or where surgical resection is likely to result in severe morbidity. Escherichia coli, klebsiella pneumoniae, citrobacter. Information for the patient xgeva 120 mg solution for injection denosumab read all of this leaflet carefully before you start using this medicine because it contains important information for. View important safety information and full prescribing information on. Xgeva is a sterile, preservativefree, clear, colorless to pale yellow solution.
Zytiga is used to treat men with prostate cancer that has spread to other parts of the body. Zytiga abiraterone acetate is a prescription medicine that is used along with prednisone. Infusion reactions andcardiopulmonary arrest see full prescribing information for complete boxed warning. May worsen, especially in patients with renal impairment. Information for the patient xgeva 120 mg solution for injection denosumab read all of this leaflet carefully before you start using this medicine because it contains important information for you. Xgeva is indicated for the treatment of hypercalcemia of malignancy refractory to bisphosphonate therapy. Xgeva is a clear, colorless to pale yellow solution that may contain trace amounts of translucent to. Xgeva is indicated for the prevention of skeletalrelated events in patients with bone metastases from solid tumors. Monitor levels more frequently when xgeva is administered with other drugs that can also lower calcium levels. Xgeva product monograph page 4 of 63 pediatrics the safety and efficacy of xgeva have not been studied in pediatric populations other than skeletally mature adolescents aged 17 years with giant. Easy to read fda package insert, drug facts, dosage and administration, and adverse effects for prolia denosumab skip to. Information for the user prolia 60 mg solution for injection in prefilled syringe denosumab read all of this leaflet carefully before you start using this medicine because it contains. Serious bone problem prevention xgeva denosumab injection.
The drug should be used with caution in patients with coronary. Prepare the prefilled syringe by attaching the plunger. Monitor calcium levels, throughout xgeva therapy, especially in the first weeks of initiating therapy, and administer calcium, magnesium, and vitamin d as necessary. May 09, 2019 visually inspect xgeva for particulate matter and discoloration prior to administration. Xgevadenosumab injection, for subcutaneous use initial usapproval. If you have any further questions, ask your doctor, pharmacist, or nurse. Specialty guideline management xgeva denosumab policy. You will only feel light resistance when screwing the plunger rod into position. Patients treated with xgeva should be given the package leaflet and the patient reminder card. The indications below including fdaapproved indications and compendial uses are considered a covered benefit provided that all the approval. Adequately supplement patients with calcium and vitamin d 5. Xgeva denosumab is a human igg2 monoclonal antibody that binds to human rankl. Shared care arrangement and prescribing information for.
Xgeva is intended for subcutaneous route only and should not be administered intravenously, intramuscularly, or intradermally. Prescription treatment with zytiga abiraterone acetate. Xgeva injection for subcutaneous use prescribing information. Do not use if the solution is discolored or cloudy or if the solution contains many particles or foreign particulate matter. Highlights of prescribing information procrit epoetin alfa. For subsequent monthly doses for both of the above scenarios. Xerava is indicated for the treatment of complicated intraabdominal infections ciai caused by susceptible microorganisms. Attach the adapter to the powder vial by pressing the adapter down until the spike pushes through the rubber stopper and the adapter snaps in place see figure a. Highlights of prescribing information hypocalcemia may worsen. Visually inspect xgeva for particulate matter and discoloration prior to administration. Page 1 highlights of prescribing information these. Prevention of skeletal related events in adults with advanced. Denosumab prolia, xgeva related to lcd l33394 a52399. Information for the user prolia 60 mg solution for injection in prefilled syringe denosumab read all of this leaflet carefully before you start using this medicine because it contains important information for you.
Xgeva 3 level of xgeva wasand were previously authorized by hmsacvs and members demonstrate a response to xgeva therapy defined as albumincorrected serum calcium level of xgeva should be administered under the responsibility of a healthcare professional. Use a 27gauge needle to withdraw and inject the entire contents of the vial. Erbitux can cause serious and fatal infusion reactions. The infusion time must not be less than 15 minutes given over a constant infusion rate. Xgeva is a clear, colorless to pale yellow solution that may contain trace amounts of translucent to white proteinaceous particles.
Learn about a medicine used to help prevent serious bone problems in patients with multiple myeloma or from solid tumors. Xgeva is indicated for the prevention of skeletalrelated events in patients with multiple myeloma and in patients with bone metastases from solid tumors. Page 3 full prescribing information 1 indications and usage 1. Indications the indications below including fdaapproved indications and compendial uses are considered a covered benefit.
Insert the plunger rod into the prefilled syringe containing sterile water, usp, and screw the plunger rod clockwise to tighten. Prolia denosumab injection, for subcutaneous use initial u. If you have any further questions, ask your doctor or pharmacist. Xgeva fda prescribing information, side effects and uses. Discontinue permanently if a clinically significant reaction occurs 5. Highlights of prescribing information these highlights do not include all the information needed to use reclast safely and effectively. Highlights of prescribing information these highlights do not include all theinformation needed to use xgevasafely and effectively. For prevention of skeletal related events in patients with bone. For subsequent monthly doses for both of the above scenarios, instruct patients to return to their original schedule by taking one boniva 150 mg tablet every month on their previous chosen day. Highlights of prescribing information these highlights do not include all the information needed to use prolia safely and effectively. Prolia is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture.
Page 3 of 44 full prescribing information 1 indications and usage 1. Insert needle and inject all the liquid subcutaneously. Highlights of prescribing information hypocalcemia. Monitor calcium levels during therapy, especially in the first weeks of initiating therapy, and adequately supplement all patients with calcium and vitamin d 5. Clinical reasons to avoid iv bisphosphonate therapy renal insufficiency creatinine clearance desmopressin acetate 4 mcgml has infrequently produced changes in blood pressure causing either a slight elev ation in blood pressure or a transient fall in blood pressure and a compensatory increase in heart rate. Denosumab has an approximate molecular weight of 147 kda and is produced in genetically engineered mammalian chinese hamster ovary cells. Sca and prescribing information for denosumab 120mg injection xgeva. Perform an oral examination prior to starting xgeva. Refer to the full prescribing information ofcoadministeredpalbociclib,abemaciclib,or ribociclibfor dose modification guidelines in the eventof toxicities, for use with concomitant medications, and other relevant safety information. To prepare reduced doses for patients with baseline crcl less than or equal to 60 mlmin, withdraw the. Highlights of prescribing information adequately rehydrate.
1515 84 886 103 917 275 646 358 960 657 398 475 563 528 506 224 749 13 332 846 1105 668 424 1366 1323 1303 473 1433 45 870 1491 969 405 1259 177 815 1419